Topical corticosteroids remain a cornerstone of atopic dermatitis care, but steroid phobia and a growing roster of nonsteroidal agents are reshaping how clinicians use them. On this episode…
Exosomes in dermatology are moving closer to a regulatory pathway, and a new remibrutinib label update is changing how clinicians approach symptomatic dermographism. Todd Schlesinger, MD, shares the…
Atopic Dermatitis 3.0: from clinical phenotypes to biomarker based endophenotypes DirkJan Hijnen, MD PhD | Rotterdam, Netherlands Associate Professor Dept of Dermatology, Erasmus University Medical Center
